Baxiva
1 known investors
Baxiva is a biotechnology startup developing glycoconjugate vaccines to prevent bacterial infections with high clinical burden and antimicrobial resistance. Its lead program targets urinary tract and invasive infections caused by Escherichia coli.
BiotechHealthtech